These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The new biotechnology law and the old maternal age criterium]. Solberg B Tidsskr Nor Laegeforen; 2003 Oct; 123(19):2741-3. PubMed ID: 14600751 [No Abstract] [Full Text] [Related]
3. [Is early ultrasonography good for everyone?]. Berg SF Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1588-9. PubMed ID: 22875118 [No Abstract] [Full Text] [Related]
4. Profile: Einer Elhauge. Ratner M Nat Biotechnol; 2006 Feb; 24(2):125. PubMed ID: 16465144 [No Abstract] [Full Text] [Related]
5. Prenatal screening for Down syndrome: tempering practice with policy. Haddow JE Ultrasound Obstet Gynecol; 2002 Jul; 20(1):103-4. PubMed ID: 12100435 [No Abstract] [Full Text] [Related]
6. [Self-determination by means of solidarity]. Hofmann B Tidsskr Nor Laegeforen; 2006 Mar; 126(6):790. PubMed ID: 16541176 [No Abstract] [Full Text] [Related]
7. [Informed choice--important also for Norwegian pregnant women]. Solberg B Tidsskr Nor Laegeforen; 2009 Jun; 129(13):1346-8. PubMed ID: 19561662 [No Abstract] [Full Text] [Related]
8. How accurate is a second-trimester prenatal ultrasound in the diagnosis of Down syndrome? Smalley C J Fam Pract; 2001 Jun; 50(6):490. PubMed ID: 11401731 [No Abstract] [Full Text] [Related]
9. Are the Norwegian guidelines for ultrasound in prenatal diagnosis followed? Røe K; Salvesen KA; Eggebø TM Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1603-7. PubMed ID: 22875123 [TBL] [Abstract][Full Text] [Related]
10. [New biotechnology legislation--only a milestone on the way?]. Folstad T; Magelssen M; Heen E Tidsskr Nor Laegeforen; 2007 Jan; 127(2):205. PubMed ID: 17237873 [No Abstract] [Full Text] [Related]
11. The power and politics of fetal imagery. Callender B; Carlyle M; Chor J Lancet; 2021 Oct; 398(10307):1208-1209. PubMed ID: 34600616 [No Abstract] [Full Text] [Related]
12. [From politics to ethics--obstetric ultrasound in 1980's and 1990's]. Kvande L Tidsskr Nor Laegeforen; 2008 Dec; 128(24):2855-9. PubMed ID: 19092965 [No Abstract] [Full Text] [Related]
13. The 1992 biotechnology agenda: a message for candidates Bush and Clinton. Duzan SA Healthspan; 1992 Sep; 9(8):12-5. PubMed ID: 10122052 [No Abstract] [Full Text] [Related]
14. [People and biotechnology--a heering statement from the Medical Society]. Apold J; Haugen DR Tidsskr Nor Laegeforen; 1992 Apr; 112(10):1334-5. PubMed ID: 1579921 [No Abstract] [Full Text] [Related]
15. Is the FDA regulating the practice of medicine? Aicher RH Aesthet Surg J; 2013 Mar; 33(3):452-5. PubMed ID: 23515389 [No Abstract] [Full Text] [Related]
16. The role of ultrasound in screening for Down syndrome. Resta RG; Nyberg D Birth Defects Orig Artic Ser; 1990; 26(3):104. PubMed ID: 2151180 [No Abstract] [Full Text] [Related]
17. Towards harmonization: the European biotechnology patent directive. Curley D J Biolaw Bus; 2002; 5(3):64-8. PubMed ID: 12816122 [TBL] [Abstract][Full Text] [Related]
18. Evidence & Ethics: Once More into the Fray. Quigley M J Med Ethics; 2015 Oct; 41(10):793-4. PubMed ID: 26405115 [No Abstract] [Full Text] [Related]
19. [Prenatal ultrasonography and Down's syndrome]. Skauge T Tidsskr Nor Laegeforen; 1991 Jan; 111(1):97-8. PubMed ID: 1825734 [No Abstract] [Full Text] [Related]
20. Ultrasound markers of fetal Down syndrome. Nyberg DA JAMA; 2001 Jun; 285(22):2856; author reply 2858. PubMed ID: 11401602 [No Abstract] [Full Text] [Related] [Next] [New Search]